Locations
Stockholm, Sweden · Zug, Switzerland · San Francisco, CA, USA · Boston, MA, USA · United States
industry
Information Technology · Software · Health · Biotechnology
Size
51-200 employees
Stage
Series A
founded in
2017
PharmaCCX is an independent, third-party technology platform created for the industry, by the industry. We are 100% focused on helping pharma and payers improve patient outcomes by more efficiently reaching access agreements in areas such as combination therapies, indication-based pricing, gene therapy and value-based deals. By using our platform, pharma companies make “contingent commitments” until they are able to agree on pricing with payers. We do not take sides — instead, we work collaboratively with all parties involved in a negotiation to help increase patient access to promising, life-saving therapies.
Something looks off?